Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Lancet (London, England)|April 25, 2006
Mild cognitive impairmentSerge Gauthier, Barry Reisberg, Michael Zaudig, et al.Pharmacological Research|February 20, 2018
Precision pharmacology for Alzheimer's diseaseHarald Hampel, Andrea Vergallo, Lisi Flores Aguilar, et al.European Archives of Psychiatry and Clinical Neuroscience|October 25, 2014
Risk of dementia in elderly patients with the use of proton pump inhibitorsBritta Haenisch, Klaus von Holt, Birgitt Wiese, et al.Journal of Psychopharmacology (Oxford, England)|October 25, 2006
Clinical practice with anti-dementia drugs: a consensus statement from British Association for PsychopharmacologyAlistair Burns, John O'Brien, , et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task ForceBruno Vellas, Maria C Carrillo, Cristina Sampaio, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2015
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive DeclineSimone Lista, Jose L Molinuevo, Enrica Cavedo, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 23, 2014
Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's diseasePatrick Bradley, Ron Akehurst, Clive Ballard, et al.The Journal of Clinical Psychiatry|August 28, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statementRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.The Journal of Clinical Psychiatry|August 3, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief reportRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2016
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Harald Hampel, Howard H Feldman, et al.Pageof 9